3 (5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S124000, C546S275400, C546S152000, C514S314000, C514S341000

Reexamination Certificate

active

07019005

ABSTRACT:
A class of pyrazole derivatives is described for use in treating p38 kinase mediated disorders. Compounds of particular interest are defined by Formula Iwherein R1, R2, Ar1and HetAr2are as described in the specification.

REFERENCES:
patent: 4000281 (1976-12-01), Beiler et al.
patent: 5932576 (1999-08-01), Anantanarayan et al.
patent: 6579873 (2003-06-01), Anantanarayan et al.
Hashimoto et al (1993): STN International CAPLUS database, (Columbus, Ohio), Accession No. 1993:472619.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

3 (5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3 (5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3 (5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3581467

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.